An isogenic human stem cell model reveals NGLY1-dependent control of microglial development

NGLY1 is a cytosolic N-glycanase involved in glycoprotein quality control and proteasome-mediated protein degradation and is critical for normal brain development and function. Although neuronal alterations caused by NGLY1 deficiency have been extensively characterized in animal and human cell models, how NGLY1 deficiency affects human glial cells, particularly microglia, the brain-resident innate immune cells, remains largely unknown. Using patient-derived NGLY1-deficient human induced pluripotent stem cell (hiPSC) lines and their corresponding CRISPR-mediated gene-corrected isogenic lines, we found that NGLY1-deficient primitive macrophage progenitors (PMPs) exhibited increased GlcNAc-Asn (GNA) accumulation and elevated expression of RUNX1, a key transcription factor regulating myeloid lineage development, accompanied by abnormal proliferation. Following further differentiation, NGLY1-deficient human microglia exhibited reduced morphological complexity and impaired phagocytic capacity. In addition, NGLY1-deficient microglia showed increased expression of pro-inflammatory cytokines, including IL-1β, IL-6, and TNFα, under both basal and stimulated conditions, indicative of a heightened inflammatory state. Mechanistically, our data showed that RUNX1 upregulation induced by NGLY1 deficiency partially mediated impaired PMP proliferation and subsequent microglial abnormalities, implicating RUNX1 dysregulation in NGLY1-associated microglial dysfunction and identifying RUNX1 as a potential therapeutic target. Together, using patient-derived and gene-corrected isogenic hiPSCs, our study establishes a human stem cell platform for modeling NGLY1 deficiency and reveals that impaired deglycosylation alters human microglial developmental trajectories and ultimately compromises microglial homeostasis and function. These microglial abnormalities may contribute to the neurological deficits observed in patients carrying loss-of-function variants in NGLY1.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-16
DOI
https://doi.org/10.64898/2026.11.13.766515
Primary Topic
Neuroinflammation and Neurodegeneration Mechanisms
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

An isogenic human stem cell model reveals NGLY1-dependent control of microglial development

Adam J. Rauckhorst, Ying Liu, Haipeng Xue, Yu-Chieh Wang et al.
2 links
bioRxiv (Cold Spring Harbor Laboratory)
Neuroinflammation and Neurodegeneration Mechanisms
preprint

An isogenic human stem cell model reveals NGLY1-dependent control of microglial development

Adam J. Rauckhorst, Ying Liu, Haipeng Xue, Yu-Chieh Wang, Mengmeng Jin, Peng Jiang, Haiwei Zhang, Ting Wang
preprint en

Abstract

NGLY1 is a cytosolic N-glycanase involved in glycoprotein quality control and proteasome-mediated protein degradation and is critical for normal brain development and function. Although neuronal alterations caused by NGLY1 deficiency have been extensively characterized in animal and human cell models, how NGLY1 deficiency affects human glial cells, particularly microglia, the brain-resident innate immune cells, remains largely unknown. Using patient-derived NGLY1-deficient human induced pluripotent stem cell (hiPSC) lines and their corresponding CRISPR-mediated gene-corrected isogenic lines, we found that NGLY1-deficient primitive macrophage progenitors (PMPs) exhibited increased GlcNAc-Asn (GNA) accumulation and elevated expression of RUNX1, a key transcription factor regulating myeloid lineage development, accompanied by abnormal proliferation. Following further differentiation, NGLY1-deficient human microglia exhibited reduced morphological complexity and impaired phagocytic capacity. In addition, NGLY1-deficient microglia showed increased expression of pro-inflammatory cytokines, including IL-1β, IL-6, and TNFα, under both basal and stimulated conditions, indicative of a heightened inflammatory state. Mechanistically, our data showed that RUNX1 upregulation induced by NGLY1 deficiency partially mediated impaired PMP proliferation and subsequent microglial abnormalities, implicating RUNX1 dysregulation in NGLY1-associated microglial dysfunction and identifying RUNX1 as a potential therapeutic target. Together, using patient-derived and gene-corrected isogenic hiPSCs, our study establishes a human stem cell platform for modeling NGLY1 deficiency and reveals that impaired deglycosylation alters human microglial developmental trajectories and ultimately compromises microglial homeostasis and function. These microglial abnormalities may contribute to the neurological deficits observed in patients carrying loss-of-function variants in NGLY1.

bioRxiv (Cold Spring Harbor Laboratory)
Rutgers, The State University of New Jersey (US), Florida International University (US)
Good health and well-being
Neuroinflammation and Neurodegeneration Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon